Consolidated Company Outline
|Company Name||Olympus Corporation|
|Market||1st section of Tokyo Stock Exchange|
|Stock Code||ISIN: JP3201200007|
|Established||October 12, 1919|
|Director, Representative Executive Officer, President and CEO||Yasuo Takeuchi|
|Head Office||Shinjuku Monolith, 3-1 Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 163-0914, Japan
|Business Lines||Manufacture and sales of precision machineries and instruments|
|Share Capital||124.60 billion yen (As of March 31, 2021)|
|Consolidated Revenue||730.5 billion yen (Fiscal year ended March 31, 2021)|
|Consolidated Headcount||31,653 (As of March 31, 2021)|
Share of Revenue by Business Segment
Our largest business domain is medical solutions business.
Medical business consist of Endoscopic Solutions and Therapeutic Solutions. They cover nearly 80% of the revenue. Especially, Endoscopic Solutions occupies the largest part.
Number of Group Companies
Revenue and Operating Profit
Note) We split off the imaging business to a special purpose company established by Japan Industrial Partners, Inc. on January 1, 2021. In this regard, imaging division is categorized as a discontinued operation, effective Q2 of FY2021 and figures of FY2020 is restated.
Revenue by Region